1-2 of 2
Carl Schaper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay

Aleix Prat, Patricia Galván, Begoña Jimenez, Wesley Buckingham, H. Arthur Jeiranian, Carl Schaper, Maria Vidal, Martina Álvarez, Sherley Díaz, Catherine Ellis, Paolo Nuciforo, Sean Ferree, Nuria Ribelles, Barbara Adamo, Santiago Ramón y Cajal, Vicente Peg, Emilio Alba
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (3): 560–566.
https://doi.org/10.1158/1078-0432.CCR-15-0630
Published: 31 January 2016
View article titled, Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay
Open the PDF for Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay in another window
Includes: Supplementary data
Journal Articles

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

Martin Filipits, Torsten O. Nielsen, Margaretha Rudas, Richard Greil, Herbert Stöger, Raimund Jakesz, Zsuzsanna Bago-Horvath, Otto Dietze, Peter Regitnig, Christine Gruber-Rossipal, Elisabeth Müller-Holzner, Christian F. Singer, Brigitte Mlineritsch, Peter Dubsky, Thomas Bauernhofer, Michael Hubalek, Michael Knauer, Harald Trapl, Christian Fesl, Carl Schaper, Sean Ferree, Shuzhen Liu, J. Wayne Cowens, Michael Gnant, for the Austrian Breast and Colorectal Cancer Study Group
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (5): 1298–1305.
https://doi.org/10.1158/1078-0432.CCR-13-1845
Published: 02 March 2014
View article titled, The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
Open the PDF for The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer in another window
Includes: Supplementary data